Sound Physicians Presents 2013 Summit Award to Chief Hospitalist Rana Tan, MD

Harrison Medical Center's Chief Hospitalist, Rana Tan, MD, earns honor at national leadership conference.

2013-05-07

TACOMA, WA, May 07, 2013 (Press-News.org) Sound Physicians, a leading hospitalist organization focused on driving improvements in quality, satisfaction and financial performance of inpatient healthcare delivery, announced that Rana Tan, MD, Chief Hospitalist at Harrison Medical Center in Bremerton, Wash., is the recipient of Sound Physicians' 2013 Summit Award, which honors hospitalists who display exemplary performance of Sound Physicians' organizational values.

Trained as an intensivist, Dr. Tan has been a Sound Physicians hospitalist since 2005. In 2010, she was named Chief Hospitalist at Harrison Medical Center, one of Sound Physicians 70+ hospital partners. Since then, Dr. Tan has led the 16-member hospitalist team in improving core measures compliance, dramatically raising HCAHPS scores for inpatients, and collaborating with other specialties. In 2012, Harrison Medical Center credited Dr. Tan with the "Buck Stops Here" award for her can-do attitude, instrumental assistance in fine-tuning the inpatient EMR system, and enhanced communication with community-based physicians and hospital colleagues.

"Dr. Tan has single-handedly been responsible for the on-the-ground, frontline leadership transformation of the Harrison Medical Center program," said Juhie Parnami, Sound Physicians' Northwest regional vice president. "With an 'action plan' in place to improve relationships, engagement, core measures and patient satisfaction, Dr. Tan tackled each area with rigor and laser focus. We credit a tremendous amount to Dr. Tan and feel she deserves the Sound Physicians Summit Award."

The Sound Physicians National Leadership Conference is an annual event, bringing together Sound Physicians' Chief Hospitalists and Hospitalist RNs for a two-day intensive leadership development program. Sound Physicians has been providing its annual Summit Award at the National Leadership Conference since 2012. Past winners include Matthew Harbison, MD, medical director of the Sound Physicians team at Memorial Hermann-Texas Medical Center.

About Sound Physicians
Sound Physicians is a leading hospitalist organization focused on driving improvements in quality, satisfaction and efficiency of inpatient health care delivery. By investing deeply in outstanding physicians, clinical process excellence and its proprietary workflow and informatics technology, Sound Physicians improves the delivery of inpatient care. Sound Physicians aligns with healthcare providers to measurably enhance patient outcomes and strengthen its partners' financial performance. The organization is the practice of choice of more than 650 hospitalist and post-acute physicians. To learn more visit: www.soundphysicians.com.

ELSE PRESS RELEASES FROM THIS DATE:

Assembly of a protein degradation machine could lead to treatments in cancer, neurological diseases

2013-05-06

MANHATTAN, Kan. -- Kansas State University scientists helped discover new details about an intricate process in cells. Their finding may advance treatments for cancer and neurological diseases. Kansas State University researchers Jeroen Roelofs, assistant professor, and Chingakham Ranjit Singh, research assistant professor -- both in the Division of Biology -- led part of the study. Both also are research affiliates with the university's Johnson Cancer Research Center. They worked with colleagues at Harvard Medical School, the University of California-San Francisco and ...

Flu vaccine safe for children with IBD: Study

2013-05-06

TORONTO and OTTAWA, May 6, 2013 – Influenza immunization rates in children with inflammatory bowel disease (IBD) are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences (ICES), Children's Hospital of Eastern Ontario (CHEO), the Ottawa Hospital Research Institute (OHRI), and the University of Ottawa. Yearly influenza immunization is recommended in patients with IBD, including sub-types of Crohn's disease and ulcerative colitis. However, concern about vaccine-related adverse events may limit uptake. Given that ...

Minimally-invasive failed biological aortic valve replacement successful in high risk patients

2013-05-06

Minneapolis, MN, May 6, 2013 – When a biologic aortic valve prosthesis fails, the patient often faces a high risk valve replacement through repeat open heart surgery. A new technique, known as Valve-in-Valve, uses minimally invasive techniques to introduce a collapsible aortic heart valve into the damaged valve in order to restore function. This procedure avoids the need to open the chest or use cardiopulmonary bypass (heart-lung machine), according to Leo Ihlberg, MD, PhD, a cardiothoracic surgeon at the Heart and Lung Center of Helsinki University Hospital, Finland, ...

Kidney disease in Canada: 12.5 percent of adults afflicted, yet many unaware

2013-05-06

An estimated 12.5% of Canadians in Canada have evidence of chronic kidney disease, including people without risk factors such as high blood pressure and diabetes, according to a study published in CMAJ. Chronic kidney disease is a risk factor for death, and it places a significant burden on the health care system; dialysis for 1 person alone over 1 year costs about $60 000. Estimates of kidney disease in Canada are based on extrapolations of the prevalence of end-stage renal disease. In this study, researchers looked at blood and urine samples from 3689 participants ...

Single, high-dose erythropoietin given 2 days pre-op reduces need for transfused blood

2013-05-06

Minneapolis, MN, May 6, 2013 – Anemia increases operative mortality and morbidity in non-cardiac and cardiac surgical procedures. Anemic surgical patients may require more blood transfusions, raising the risk of transfusion-related complications and increasing costs. For those reasons, optimizing patient readiness by correcting anemia prior to surgery is an important clinical goal. A simple new protocol has been proposed that helps correcting anemia using a single, high dose of recombinant human erythropoietin (HRE) administered only two days prior to surgery. The results ...

Managing fibromyalgia: A guide for physicians

2013-05-06

Fibromyalgia, now recognized as a true health syndrome with origins in the central nervous system, has seen many recent evolutions regarding its diagnosis and management which should instil new approaches, states a review article published in CMAJ. "The cause of fibromyalgia is unknown, but there is some evidence for a genetic predisposition, abnormalities in the stress response system or hypothalamic–pituitary axis, and possible triggering events," writes Dr. Mary-Ann Fitzcharles, Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University, ...

Minimal dose CT superior to chest X-ray for detection of recurrent lung cancer

2013-05-06

Minneapolis, MN, May 6, 2013 – Lung cancer is associated with very high mortality, in part because it is hard to detect at early stages, but also because it can recur frequently after surgical removal. The question arises as to what is the best way to follow lung cancer patients after surgery in order to spot problems early enough, before symptoms become obvious, so that patients may still be eligible for new interventions. In this study presented at the 93rd AATS Annual Meeting, investigators from the University of Toronto departments of Thoracic Surgery and Diagnostic ...

Low-dose anticoagulation therapy used with new design mechanical heart valve lowers bleeding risk

2013-05-06

Minneapolis, MN, May 6, 2013 – For more than 40 years, patients under 65 years of age requiring heart valve replacement have had to choose between a mechanical valve that offers life-long durability but requires aggressive warfarin anticoagulation or a biological (cow or pig) valve that will wear out in 10-20 years but does not require anticoagulation. Aggressive warfarin anticoagulation is accompanied by significant annual risk of bleeding, while inadequate anticoagulation of a mechanical artificial valve has been associated with high risk of clotting problems that can ...

Activity of cancer inducing genes can be controlled by the cell's skeleton

2013-05-06

Cancer is a complex disease, in which cells undergo a series of alterations, including changes in their architecture; an increase in their ability to divide, to survive and to invade new tissues or metastasis. A category of genes, called oncogenes, is critical during cancer progression, as they codify proteins whose activity favours the development of cancer. One of these molecules, Src, is implicated in a large number of human cancers. However, it is still not clear how healthy cells constrain its activity not to become tumorous. In the latest issue of the journal Oncogene*, ...

Progerin's 'discrimination' may contribute to fatal disease HGPS

2013-05-06

A mutant protein responsible for Hutchinson-Gilford Progeria syndrome (HGPS) bars large proteins from entering the nucleus, according to a study in The Journal of Cell Biology. The culprit in HGPS, a fatal disease that resembles premature aging, is a protein variant called Progerin. This defective protein impairs cells in many ways, including reducing nuclear levels of the RanGTPase. Ran is crucial for nuclear import and export, as it stimulates unloading of cargo that has just entered the nucleus and loading of cargo that's ready to exit. Progerin also impedes the import ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease